Back to Search
Start Over
Neobladder and ablative pelvic radiotherapy: still a taboo?
- Source :
-
Tumori [Tumori] 2021 Dec; Vol. 107 (6), pp. NP108-NP113. Date of Electronic Publication: 2021 Jul 08. - Publication Year :
- 2021
-
Abstract
- The presence of a neobladder constitutes a limitation for the radiation oncologist, as there is no clear evidence about its tolerance to radiotherapy (RT). The limited literature only concerns the conventional postoperative treatment in patients with bladder cancer after cystectomy. Here we report a case of a patient with neobladder who underwent a stereotactic RT for a pelvic recurrence of disease, with response to treatment and no toxicity to the neobladder. This case represents a promising example of the chance to perform RT with ablative intent, using advanced techniques, even on lesions close to the neobladder.
- Subjects :
- Clinical Decision-Making
Cystectomy adverse effects
Cystectomy methods
Disease Management
Humans
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Staging
Organ Sparing Treatments
Organs at Risk
Pelvis radiation effects
Tomography, X-Ray Computed
Treatment Outcome
Urinary Bladder Neoplasms complications
Urinary Bladder Neoplasms diagnosis
Urinary Bladder Neoplasms surgery
Postoperative Care
Radiofrequency Therapy adverse effects
Radiofrequency Therapy methods
Urinary Bladder Neoplasms radiotherapy
Subjects
Details
- Language :
- English
- ISSN :
- 2038-2529
- Volume :
- 107
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Tumori
- Publication Type :
- Academic Journal
- Accession number :
- 34235994
- Full Text :
- https://doi.org/10.1177/03008916211031295